Company Filing History:
Years Active: 2014-2020
Introduction
Elisa Liberati is a pioneering inventor based in Rome, Italy, recognized for her contributions in the field of glycogen-based polymers. With an impressive portfolio of five patents, she has made significant strides in enhancing the solubility of lipophilic compounds, leading to advancements in pharmaceutical and nutraceutical applications.
Latest Patents
Elisa's recent inventions include two notable patents. The first is focused on glycogen-based water solubility enhancers. This invention relates to glycogen-based polymers that enhance the solubility in water of lipophilic compounds. It also involves the formation of complexes between these polymers and lipophilic compounds, paving the way for innovative pharmaceutical, nutraceutical, and cosmetic compositions.
The second patent introduces glycogen-based cationic polymers. This invention pertains to the use of glycogen-based cationic polymers in creating complexes with anionic compounds. These complexes are crucial for delivering or transfecting anionic compounds to specific pharmacological targets, such as tissues and cells, thereby holding potential for extensive medical applications.
Career Highlights
Elisa is currently working at Aziende Chimiche Riunite Angelini Francesco A.c.r.a.f. S.p.a., a reputable company known for its commitment to research and innovation in the chemical and pharmaceutical sectors. Her work there has been pivotal in pushing the boundaries of current scientific knowledge and applications.
Collaborations
Throughout her career, Elisa has collaborated with fellow innovators, including Vincenzo Russo and Leonardo Marchitto. Their joint efforts have fostered a productive environment that encourages groundbreaking research and development.
Conclusion
Elisa Liberati stands out as a remarkable inventor whose work with glycogen-based polymers is shaping the future of solubility enhancement in various compounds. Her patents not only contribute to the scientific community but also promise substantial benefits in the pharmaceutical and cosmetic industries. As she continues her innovative journey, Elisa remains a key figure in the field of biomedical research and development.